Literature DB >> 18388952

Facile synthesis of mono-6-amino-6-deoxy-alpha-, beta-, gamma-cyclodextrin hydrochlorides for molecular recognition, chiral separation and drug delivery.

Weihua Tang1, Siu-Choon Ng.   

Abstract

We describe a protocol for the synthesis of mono-6-amino-6-deoxy-cyclodextrin hydrochloride (CD-NH3Cl), applicable to alpha-, beta- and gamma-cyclodextrin. These structurally simplest, highly water-soluble cationic cyclodextrins can be widely used in molecular recognition, chiral separation and drug delivery studies. Starting from commercially available chemicals, CD-NH3Cl is synthesized in four steps: (i) selective tosylation of cyclodextrin by the use of p-toluenesulfonyl chloride to afford mono-6-(p-toluenesulfonyl)-6-deoxy-cyclodextrin (Ts-CD); (ii) azide substitution of Ts-CD with sodium azide to afford mono-6-azido-6-deoxy-cyclodextrin (CD-N3); (iii) reduction of CD-N3 with triphenylphospine followed by hydrolysis to prepare mono-6-amino-6-deoxy-cyclodextrin (CD-NH2); and (iv) treatment of CD-NH2 with hydrochloric acid to afford the titled CD-NH3Cl with good yield. The overall protocol requires approximately 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388952     DOI: 10.1038/nprot.2008.37

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  20 in total

1.  Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.

Authors:  Min Xue; Wei Wei; Yapeng Su; Dazy Johnson; James R Heath
Journal:  J Am Chem Soc       Date:  2016-02-26       Impact factor: 15.419

2.  Preparation of cyclodextrin chiral stationary phases by organic soluble catalytic 'click' chemistry.

Authors:  Yong Wang; Hui Chen; Yin Xiao; Cheong Hengq Ng; Ting Shan Oh; Timothy Thatt Yang Tan; Siu Choon Ng
Journal:  Nat Protoc       Date:  2011-06-09       Impact factor: 13.491

3.  Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs.

Authors:  Cheoljin Kim; Birju P Shah; Prasad Subramaniam; Ki-Bum Lee
Journal:  Mol Pharm       Date:  2011-08-05       Impact factor: 4.939

4.  Effect of pendant group on pDNA delivery by cationic-β-cyclodextrin:alkyl-PVA-PEG pendant polymer complexes.

Authors:  Aditya Kulkarni; Vivek Badwaik; Kyle DeFrees; Ryan A Schuldt; Dinara S Gunasekera; Cory Powers; Alexander Vlahu; Ross VerHeul; David H Thompson
Journal:  Biomacromolecules       Date:  2013-12-02       Impact factor: 6.988

5.  Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.

Authors:  Jinping Lai; Birju P Shah; Eric Garfunkel; Ki-Bum Lee
Journal:  ACS Nano       Date:  2013-03-11       Impact factor: 15.881

6.  Dynamic display of bioactivity through host-guest chemistry.

Authors:  Job Boekhoven; Charles M Rubert Pérez; Shantanu Sur; Amanda Worthy; Samuel I Stupp
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-24       Impact factor: 15.336

7.  Microfluidic Assembly of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantane Host:Guest pDNA Nanoparticles.

Authors:  Aditya Kulkarni; Ross Verheul; Kyle Defrees; Christopher J Collins; Ryan A Schuldt; Alexander Vlahu; David H Thompson
Journal:  Biomater Sci       Date:  2013-10-01       Impact factor: 6.843

8.  Enhanced Cellular Uptake Of Phenamil Through Inclusion Complex With Histidine Functionalized β-Cyclodextrin As Penetrative Osteoinductive Agent.

Authors:  Vahid Jahed; Ebrahim Vasheghani-Farahani; Fatemeh Bagheri; Ali Zarrabi; Trine Fink; Kim Lambertsen Larsen
Journal:  Int J Nanomedicine       Date:  2019-10-11

9.  Lipase mimetic cyclodextrins.

Authors:  Youngjun Lee; Neal K Devaraj
Journal:  Chem Sci       Date:  2020-11-19       Impact factor: 9.825

10.  Engineering Cyclodextrin Clicked Chiral Stationary Phase for High-Efficiency Enantiomer Separation.

Authors:  Jian Tang; Shapopeng Zhang; Yuzhou Lin; Jie Zhou; Limin Pang; Xuemei Nie; Baojing Zhou; Weihua Tang
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.